Development and validation of a risk prediction score for the severity of acute hypertriglyceridemic pancreatitis in Chinese patients

doi:10.3748/wjg.v28.i33.4846

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 33

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4510)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-5) series.

Item

Count

PDF

254

WORD

HTML

2636

Figures (1-5)

226

Tables (1-5)

231

Sum=3409

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

330

Download

771

Sum=1101

Sep 7, 2022 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Sep 7, 2022; 28(33): 4846-4860
Published online Sep 7, 2022. doi: 10.3748/wjg.v28.i33.4846

Table 1 Demographic and clinical characteristics of patients in the non-severe acute pancreatitis and severe acute pancreatitis groups

Patient characteristics	All (n = 243)	Non-SAP (n = 181)	SAP (n = 62)	P value
Demographic variables
Sex, n (%)				0.297
Male	188 (77.37)	143 (79.00)	45 (72.60)
Female	55 (22.63)	38 (21.00)	17 (27.40)
Age (yr)	40.12 ± 10.12	39.60 ± 10.10	41.60 ± 10.20	0.190
BMI (kg/m²)	28.27 ± 4.25	28.10 ± 4.00	28.70 ± 4.90	0.367
Medical history
Diabetes, n (%)				0.648
Yes	139 (57.20)	102 (56.40)	37 (59.70)
No	104 (42.80)	79 (43.65)	25 (40.30)
Hypertension, n (%)				0.164
Yes	59 (24.28)	48 (26.50)	11 (17.70)
No	184 (75.72)	133 (73.50)	51 (82.30)
Hyperlipidemia, n (%)				0.250
Yes	152 (62.55)	64 (35.40)	27 (43.50)
No	91 (37.45)	64 (35.40)	27 (43.50)
Fatty liver, n (%)				0.073
Yes	185 (76.13)	143 (79.00)	42 (67.70)
No	58 (23.87)	38 (21.00)	20 (32.30)
Drinking, n (%)				0.483
Yes	120 (49.38)	87 (48.10)	33 (53.20)
No	123 (50.62)	94 (51.90)	29 (46.80)
Smoking, n (%)				0.386
Yes	133 (54.73)	102 (56.40)	31 (50.00)
No	110 (45.27)	79 (43.60)	31 (50.00)
Clinical signs
HR (bpm)	96.14 ± 18.17	92.23 ± 16.30	107.58 ± 18.65	< 0.001
R (bpm)	21.66 ± 5.33	20.47 ± 4.38	25.27 ± 6.21	< 0.001
SBP (mmHg)	133.50 ± 17.52	133.51 ± 16.56	133.48 ± 20.21	0.992
DBP (mmHg)	81.13 ± 12.03	80.85 ± 11.28	81.92 ± 14.08	0.548
		Non-SAP (n = 181, 74.49%)	SAP (n = 62, 25.51%)
Laboratory findings
WBC (× 10⁹/L)	12.53 ± 3.86	11.96 ± 3.63	14.41 ± 3.97	< 0.001
NLR	9.94 ± 7.27	8.82 ± 6.98	13.19 ± 7.15	< 0.001
RDW (fL)	12.87 ± 0.72	12.80 ± 0.69	13.08 ± 0.78	0.009
PLT (× 10⁹/L)	218.91 ± 61.98	216.09 ± 57.99	227.15 ± 72.30	0.226
MPV (fL)	10.75 ± 1.05	10.68 ± 1.01	10.95 ± 1.14	0.074
PDW (fL)	12.66 ± 2.22	12.47 ± 2.09	13.23 ± 2.47	0.018
TC (mmol/L)	10.15 ± 4.11	9.54 ± 3.62	11.94 ± 4.92	< 0.001
TG (mmol/L)	21.08 ± 7.50	20.17 ± 7.31	23.75 ± 7.49	0.001
H/L ratio	0.96 ± 1.36	0.96 ± 1.36	0.97 ± 1.36	0.946
ApoA1 (g/L)	1.02 ± 0.35	1.11 ± 0.34	0.75 ± 0.23	< 0.001
TBIL (μmol/L)	14.16 ± 8.29	13.81 ± 7.11	15.16 ± 11.03	0.987
AST (U/L)	29.78 ± 17.41	27.40 ± 13.03	36.76 ± 25.20	< 0.001
ALT (U/L)	31.04 ± 28.70	30.80 ± 29.94	31.73 ± 24.94	0.826
ALP (U/L)	73.91 ± 25.30	73.59 ± 22.70	74.84 ± 31.88	0.737
ALB (g/L)	41.57 ± 5.91	42.22 ± 5.53	39.66 ± 6.58	0.003
BUN mmol/L	4.32 ± 2.03	4.05 ± 1.39	5.10 ± 3.12	< 0.001
Cr (μmol/L)	62.62 ± 42.98	56.64 ± 15.83	80.10 ± 78.56	< 0.001
fT3 (pmol/L)	1.97 ± 0.37	1.99 ± 0.36	1.91 ± 0.41	0.134
CRP (mg/L)	160.20 ± 127.36	133.55 ± 112.64	237.99 ± 136.59	< 0.001
PCT (ng/mL)	0.80 ± 1.93	0.59 ± 1.72	1.42 ± 2.35	0.003
ESR (mm/h)	42.57 ± 24.76	40.71 ± 25.10	47.99 ± 23.06	0.045
Na (mmol/L)	133.97 ± 4.29	134.28 ± 4.09	133.07 ± 4.76	0.054
K (mmol/L)	4.02 ± 0.46	3.97 ± 0.35	4.19 ± 0.67	0.080
Ca²⁺(mmol/L)	2.13 ± 0.26	2.19 ± 0.18	1.96 ± 0.36	< 0.001
PT (s)	13.26 ± 0.98	13.12 ± 0.84	13.68 ± 1.21	< 0.001
APTT (s)	37.82 ± 5.28	37.35 ± 5.14	39.22 ± 5.45	0.016
TT (s)	15.07 ± 1.10	15.08 ± 1.09	15.05 ± 1.13	0.823
FIB (g/L)	5.70 ± 2.21	5.41 ± 2.10	6.56 ± 2.32	< 0.001
D-dimer (μg/L)	1.34 ± 1.83	0.94 ± 0.98	2.51 ± 2.94	< 0.001
Imaging results
Pleural effusion, n (%)				< 0.001
Yes	69 (28.40)	23 (12.71)	46 (74.19)
No	174 (71.61)	158 (87.30)	16 (25.81)

BMI: Body mass index; RR: Respiratory rate; HR: Heart rate; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; SAP: Severe acute pancreatitis; Non-SAP: Mild acute pancreatitis and moderately sever acute pancreatitis; WBC: White blood cell; NLR: Neutrophil to lymphocyte ratio; RDW: Red blood cell distribution width; PLT: Platelet counts; RDW: MPV Mean platelet volume; PDW: Platelet distribution width; TC: Total cholesterol; TG: Triglyceride; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; ApoA1: Apolipoprotein A1; TBIL: Total bilirubin; AST: Aspartate transaminase; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; ALB: Albumin; BUN: Blood urea nitrogen; Cr: Creatinine; fT3: Free triiodothyronine; CRP: C-reactive protein; PCT: Procalcitonin; Na: Sodium; K: Potassium; Ca²⁺: Calcium; PT: Prothrombin time; APTT: Activated partial thromboplastin time; TT: Thrombin time; FIB: Fibrinogen; SAP: Severe acute pancreatitis; Non-SAP: Mild acute pancreatitis and moderately sever acute pancreatitis.

Citation: Liu ZY, Tian L, Sun XY, Liu ZS, Hao LJ, Shen WW, Gao YQ, Zhai HH. Development and validation of a risk prediction score for the severity of acute hypertriglyceridemic pancreatitis in Chinese patients. World J Gastroenterol 2022; 28(33): 4846-4860
URL: https://www.wjgnet.com/1007-9327/full/v28/i33/4846.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i33.4846